Physician profile
Ryan Hall
NPI 1295293108
$4,181.83
in general payments reported to CMS, 2019-2025
18 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $455 · 2022: $828 · 2023: $781 · 2024: $806 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,735 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,734.66 |
| Education | $163.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $718.11 | 2022-2025 | Enbrel, Otezla, Evenity |
| Abbvie INC. | $707.21 | 2021-2025 | |
| Janssen Biotech, INC. | $617.60 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Astrazeneca Pharmaceuticals Lp | $356.84 | 2021-2025 | Saphnelo |
| Lilly USA, LLC | $282.87 | 2021-2024 | Taltz |
| Ucb, INC. | $249.83 | 2021-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $222.63 | 2021-2025 | |
| Glaxosmithkline, LLC. | $196.00 | 2021-2025 | Benlysta, Nucala |
| Mallinckrodt Hospital Products INC. | $169.40 | 2021-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $157.45 | 2022-2025 | |
| Aurinia Pharma U.S., INC. | $138.03 | 2022-2025 | Lupkynis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.07 | 2021-2025 | Ofev |
| Genentech USA, INC. | $61.06 | 2023-2024 | Actemra, Rituxan |
| Horizon Therapeutics Plc | $51.19 | 2022-2023 | Krystexxa |
| Radius Health, INC. | $39.73 | 2021-2024 | Tymlos |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $39.69 | 2022-2025 | Orencia |
| Teva Pharmaceuticals USA, INC. | $37.23 | 2023-2024 | Simlandi, Truxima |
| Almatica Pharma LLC | $24.89 | 2024 | Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.